1. ACT-1 A PROSPECTIVE MULTICENTER PHASE I/IIA STUDY OF PREOPERATIVE NEOADJUVANT BEVACIZUMAB FOR NEWLY DIAGNOSED GLIOBLASTOMA. (3rd December 2022) Authors: Tanaka, Toshihide; Tamura, Ryota; Takei, Jun; Morimoto, Yukina; Teshigawara, Akihiko; Tohmoto, Kyoichi; Kuranari, Yuki; Imai, Ryotarou; Yamamoto, Yohei; Hasegawa, Yuzuru; Akasaki, Yasuharu; Murayama, Yuichi; Miyake, Keisuke; Sasaki, Hikaru Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACT-11 CLINICAL BENEFIT OF ADD-ON BEVACIZUMAB FOR NEWLY DIAGNOSED GLIOBLASTOMA IN ELDERLY PATIENTS WITH UNRESECTABLE AND POOR PERFORMANCE STATUS. (3rd December 2022) Authors: Tomoto, Kyoichi; Yamamoto, Yohei; Tanaka, Toshihide; Suzuki, Tomoya; Teshigawara, Akihiko; Takei, Jun; Koseki, Hirokazu; Mori, Ryosuke; Akasaki, Yasuharu; Murayama, Yuichi Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ANGI-01 ALTERATION IN IMMUNE REGULATORY CELLS BEFORE AND AFTER TREATMENT BY STUPP REGIMEN WITH OR WITHOUT BEVACIZUMAB FOR GLIOBLASTOMA. (16th December 2019) Authors: Tanaka, Toshihide; Tamura, Ryota; Yamamoto, Yohei; Morimoto, Yukina; Teshigawara, Akihiko; Tochigi, Satoru; Hasegawa, Yuzuru; Takei, Jun; Akasaki, Yasuharu; Sasaki, Hikaru; Murayama, Yuichi Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ANGI-1 ASSESSING THE THERAPEUTIC EFFECT OF BEVACIZUMAB USING FMISO-PET IN GBM THERAPY. (3rd December 2022) Authors: Suzuki, Tomoya; Tanaka, Toshihide; Takei, Jun; Miyake, Keisuke; Suzuki, Kenta; Ogawa, Daisuke; Akasaki, Yasuharu; Yuichi, Murayama Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ANGI-1 Impact of neoadjuvant bevacizumab on transcriptional factor for stemness, macrophage polarization, and oxygenation of tumor microenvironment in glioblastoma. (6th December 2021) Authors: Tanaka, Toshihide; Takei, Jun; Teshigawara, Akihiko; Tohmoto, Kyoichi; Yamamoto, Yohei; Hasegawa, Yuzuru; Tamura, Ryouta; Sasaki, Hikaru; Akasaki, Yasuharu; Murayama, Yuichi Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 6 Page Start: vi1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BIOM-07. LOW EXPRESSION OF HLA-A AS A NOVEL PROGNOSTIC FACTOR IN GLIOBLASTOMA TREATED WITH TUMOR FUSED DENDRITIC CELL VACCINES. (14th November 2022) Authors: Takei, Jun; Akasaki, Yasuharu; Tanaka, Toshihide; Fukasawa, Nei; Gomisawa, Kazutaka; Satake, Mari; Mori, Ryosuke; Yamamoto, Yohei; Oda, Ayaka; Kamata, Yuko; Murahashi, Mutsunori; Fukuda, Takahiro; Shimoda, Masayuki; Murayama, Yuichi Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Chronic Encapsulated Expanding Thalamic Hematoma Associated with Obstructive Hydrocephalus following Radiosurgery for a Cerebral Arteriovenous Malformation: A Case Report and Literature Review. (24th January 2016) Authors: Takei, Jun; Tanaka, Toshihide; Yamamoto, Yohei; Teshigawara, Akihiko; Tochigi, Satoru; Hasegawa, Yuzuru; Murayama, Yuichi Other Names: Huang Chin-Chang Academic Editor. Journal: Case reports in neurological medicine Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. COT-08 Analysis of prognosis of biopsy/partial resection cases of malignant glioma. (28th November 2020) Authors: Yamamoto, Yohei; Teshigawara, Akihiko; Takei, Jun; Tanaka, Toshihide; Akasaki, Yasuharu; Murayama, Yuichi Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 3 Page Start: ii22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CS-01 Rapid Recurrence and Anaplastic Transformation of a Pilocytic Astrocytoma in an Elderly Patient. (28th November 2020) Authors: Tanaka, Toshihide; Teshigawara, Akihiko; Tochigi, Satoru; Hasegawa, Yuzuru; Takei, Jun; Akasaki, Yasuharu; Murayama, Yuichi; Yokoo, Hideaki Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 3 Page Start: ii20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IMMU-12. PHASE I/II TRIAL OF IMMUNOTHERAPY WITH FUSIONS OF DENDRITIC CELLS AND TUMOR CELLS FOR RELAPSED OR REFRACTORY BRAIN TUMORS IN CHILDREN AND YOUNG ADULTS. (4th December 2020) Authors: Yamaoka, Masayoshi; Akasaki, Yasuharu; Takei, Jun; Akiyama, Masaharu; Tasaki, Tetsunori; Ohashi, Toya; Ida, Hiroyuki; Yanagisawa, Takaaki Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗